Eric Jou

593 total citations
26 papers, 298 citations indexed

About

Eric Jou is a scholar working on Surgery, Immunology and Epidemiology. According to data from OpenAlex, Eric Jou has authored 26 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 8 papers in Immunology and 6 papers in Epidemiology. Recurrent topics in Eric Jou's work include IL-33, ST2, and ILC Pathways (6 papers), Immune Cell Function and Interaction (6 papers) and Eosinophilic Esophagitis (5 papers). Eric Jou is often cited by papers focused on IL-33, ST2, and ILC Pathways (6 papers), Immune Cell Function and Interaction (6 papers) and Eosinophilic Esophagitis (5 papers). Eric Jou collaborates with scholars based in United Kingdom, Singapore and United States. Eric Jou's co-authors include Andrew N. J. McKenzie, Noé Rodríguez‐Rodríguez, Helen E. Jolin, Aydan C. H. Szeto, Jamie Sin Ying Ho, Batika M.J. Rana, Clare S. Hardman, Paula A. Clark, Stefania Carobbio and Jorge Caamaño and has published in prestigious journals such as Science, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Eric Jou

24 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Jou United Kingdom 10 168 94 70 41 33 26 298
Anca Emanuela Mușetescu Romania 8 71 0.4× 69 0.7× 41 0.6× 31 0.8× 20 0.6× 46 287
Ryoichi Maenosono Japan 11 93 0.6× 88 0.9× 51 0.7× 35 0.9× 76 2.3× 25 347
Ruxandra Ionescu Romania 9 91 0.5× 54 0.6× 42 0.6× 27 0.7× 39 1.2× 37 339
Linda Carli Italy 11 95 0.6× 47 0.5× 31 0.4× 18 0.4× 28 0.8× 19 288
Andrea Obi United States 8 75 0.4× 76 0.8× 27 0.4× 18 0.4× 48 1.5× 23 330
P. M. Kern Germany 8 108 0.6× 30 0.3× 35 0.5× 35 0.9× 70 2.1× 10 275
Shannon Haldeman United States 6 112 0.7× 47 0.5× 19 0.3× 13 0.3× 90 2.7× 10 328
Grzegorz Kandzierski Poland 8 75 0.4× 118 1.3× 74 1.1× 47 1.1× 95 2.9× 23 313
Ayşim Özağarı Türkiye 12 43 0.3× 118 1.3× 39 0.6× 54 1.3× 109 3.3× 38 318
Artur Bachta Poland 8 106 0.6× 90 1.0× 20 0.3× 10 0.2× 29 0.9× 25 386

Countries citing papers authored by Eric Jou

Since Specialization
Citations

This map shows the geographic impact of Eric Jou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Jou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Jou more than expected).

Fields of papers citing papers by Eric Jou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Jou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Jou. The network helps show where Eric Jou may publish in the future.

Co-authorship network of co-authors of Eric Jou

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Jou. A scholar is included among the top collaborators of Eric Jou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Jou. Eric Jou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ho, Jamie Sin Ying, Eric Jou, Pek‐Lan Khong, Roger Foo, & Ching‐Hui Sia. (2024). Epigenetics in Heart Failure. International Journal of Molecular Sciences. 25(22). 12010–12010. 6 indexed citations
2.
Zhou, Andrew, et al.. (2024). The evolution of poller screws. EFORT Open Reviews. 9(4). 252–263. 1 indexed citations
3.
Jou, Eric, et al.. (2024). Novel therapeutic strategies targeting myeloid-derived suppressor cell immunosuppressive mechanisms for cancer treatment. SHILAP Revista de lepidopterología. 5(1). 187–207. 12 indexed citations
4.
Jou, Eric, et al.. (2024). The role of circulating tumor DNA in melanomas of the uveal tract. Frontiers in Immunology. 15. 1509968–1509968. 1 indexed citations
5.
Jou, Eric, et al.. (2024). Emerging roles of type 1 innate lymphoid cells in tumour pathogenesis and cancer immunotherapy. Exploration of Targeted Anti-tumor Therapy. 5(2). 296–315. 7 indexed citations
7.
Szeto, Aydan C. H., Paula A. Clark, Ana C. F. Ferreira, et al.. (2024). Mef2d potentiates type-2 immune responses and allergic lung inflammation. Science. 384(6703). eadl0370–eadl0370. 15 indexed citations
8.
Jou, Eric. (2023). Type 1 and type 2 cytokine-mediated immune orchestration in the tumour microenvironment and their therapeutic potential. SHILAP Revista de lepidopterología. 4(3). 474–497. 10 indexed citations
9.
Jou, Eric, et al.. (2023). Supermicrosurgery: past, present and future. British Journal of Hospital Medicine. 84(10). 1–10. 2 indexed citations
10.
Ngiam, Jinghao Nicholas, et al.. (2023). Left ventricular vortex formation time: emerging clinical applications and limitations. Singapore Medical Journal. 67(2). 80–84. 1 indexed citations
11.
Diana, Francesco, Mohammad Mofatteh, Thanh N. Nguyen, et al.. (2023). Predictors of failure of early neurological improvement in early time window following endovascular thrombectomy: a multi-center study. Frontiers in Neurology. 14. 1227825–1227825. 12 indexed citations
12.
Jou, Eric, Mohammad Mofatteh, Thanh N. Nguyen, et al.. (2023). 7-Day National Institutes of Health Stroke Scale as a surrogate marker predicting ischemic stroke patients’ outcome following endovascular therapy. Translational Neuroscience. 14(1). 20220307–20220307. 9 indexed citations
13.
Zhou, Andrew, Eric Jou, Victor Lu, et al.. (2023). Using Pre-Clinical Studies to Explore the Potential Clinical Uses of Exosomes Secreted from Induced Pluripotent Stem Cell-Derived Mesenchymal Stem cells. Tissue Engineering and Regenerative Medicine. 20(6). 793–809. 12 indexed citations
14.
Jatoi, Ismail, Abeer M. Shaaban, Eric Jou, & John R. Benson. (2023). The Biology and Management of Ductal Carcinoma in Situ of the Breast. Current Problems in Surgery. 60(8). 101361–101361. 1 indexed citations
15.
Sun, Yu, Eric Jou, Thanh N. Nguyen, et al.. (2023). Predictors of futile recanalization after endovascular treatment in acute ischemic stroke: a multi-center study. Frontiers in Neuroscience. 17. 1279366–1279366. 14 indexed citations
16.
Jou, Eric, et al.. (2023). Prophylactic antibiotic use for infective endocarditis: a systematic review and meta-analysis. BMJ Open. 13(8). e077026–e077026. 9 indexed citations
17.
Ho, Jamie Sin Ying, Andrew Fu Wah Ho, Eric Jou, et al.. (2023). Association between the extension of smoke-free legislation and incident acute myocardial infarctions in Singapore from 2010 to 2019: an interrupted time-series analysis. BMJ Global Health. 8(10). e012339–e012339. 2 indexed citations
18.
Jou, Eric, Noé Rodríguez‐Rodríguez, & Andrew N. J. McKenzie. (2022). Emerging roles for IL-25 and IL-33 in colorectal cancer tumorigenesis. Frontiers in Immunology. 13. 981479–981479. 14 indexed citations
19.
Ho, Jamie Sin Ying, Eric Jou, Benjamin Yong‐Qiang Tan, & Vijay K. Sharma. (2022). Air Pollution and Ischaemic Stroke. Annals of Indian Academy of Neurology. 25(Suppl 1). S26–S34. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026